Pharmaceutical

STAT+: As pharmaceutical companies bemoan Medicare’s dr...

As pharmaceutical companies bemoan Medicare’s drug negotiations, hospitals and d...

A big insurer decides to cover naloxone for overdose; w...

“Waiving out-of-pocket costs for this emergency medication aligns with our commi...

Opinion: It’s long past time for a more comprehensive C...

The recent Covid mini-surge shows we need more tools to combat the virus.

No longer brushed off: A Minnesota clinic tries to rewr...

“If you neglect miscarriage, you miss that opportunity of really positively affe...

STAT+: Unicorn down: Following layoffs, Biofourmis CEO ...

Kuldeep Singh Rajput, a co-founder and CEO of Biofourmis, has quietly stepped do...

Medicaid rebukes states for mistakenly disenrolling chi...

Medicaid warned states Wednesday that they could be mistakenly removing children...

STAT+: J&J cuts the price of its lifesaving TB pill by ...

"We consider this price reduction to be a big feat,” said Brenda Waning, who hea...

Female surgeons have lower rates of long-term adverse o...

A new suggests that patients treated by female surgeons have lower rates of adve...

STAT+: Pharmalittle: Winners and losers from Medicare d...

On Tuesday, the U.S. government named 10 medicines that will be subject to Medic...

STAT+: Workforce, capacity constraints slow ramp-up of ...

Thousands of patients are stuck on waiting lists for the new Alzheimer's therapy...

Emotional dry cleaning: A writer helps doctors share th...

In virtual writing workshops, Laurel Braitman has created a place where health c...

STAT+: KRAS, the ideal cancer drug target that became ‘...

“This is the saga of the pharmaceutical industry. One or two drugs are approved ...

Opinion: How learning the truth about chaos theory has ...

A new understanding of the butterfly effect has changed how one inpatient child ...

Alvotech and Bioventure gain approval for Humira biosim...

Alvotech and Bioventure received the Egyptian Drug Authority's approval to produ...

Ipilimumab by Bristol-Myers Squibb for Metastatic Trans...

Ipilimumab is under clinical development by Bristol-Myers Squibb and currently i...

FDA shuns Outlook Therapeutics with wet AMD drug BLA re...

Shares in the company tanked 80% following the FDA issued a CRL for its bevacizu...